|
JUB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.580770E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.630400E-02 |
| Normal-vs-Stage2 |
2.548600E-01 |
| Normal-vs-Stage3 |
3.702400E-01 |
| Normal-vs-Stage4 |
8.879000E-01 |
| Stage1-vs-Stage2 |
7.368200E-01 |
| Stage1-vs-Stage3 |
4.792400E-01 |
| Stage1-vs-Stage4 |
4.512200E-01 |
| Stage2-vs-Stage3 |
8.047200E-01 |
| Stage2-vs-Stage4 |
5.617800E-01 |
| Stage3-vs-Stage4 |
6.366600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.687600E-01 |
| Normal-vs-AfricanAmerican |
9.072000E-02 |
| Normal-vs-Asian |
5.616800E-01 |
| Caucasian-vs-AfricanAmerican |
3.373400E-01 |
| Caucasian-vs-Asian |
9.819200E-01 |
| AfricanAmerican-vs-Asian |
7.521400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.034100E-02 |
| Normal-vs-Female |
8.851000E-01 |
| Male-vs-Female |
2.171600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.102210E-01 |
| Normal-vs-Extreme_Weight |
7.420300E-02 |
| Normal-vs-Obese |
8.864000E-01 |
| Normal-vs-Extreme_Obese |
6.114100E-02 |
| Normal_Weight-vs-Extreme_Weight |
9.690400E-01 |
| Normal_Weight-vs-Obese |
1.618770E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.421200E-01 |
| Extreme_Weight-vs-Obese |
1.384370E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.314400E-01 |
| Obese-vs-Extreme_Obese |
2.581000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.344600E-01 |
| Normal-vs-Age(41-60Yrs) |
9.389800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.959700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.381560E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.181400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.816580E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.298200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.224300E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.095400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.455000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.457000E-01 |
| Normal-VS-Type2 PRCC |
1.290420E-02 |
| Normal-VS-KIRP CIMP |
6.217400E-01 |
| Normal-VS-Unclassified PRCC |
7.931000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.877770E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.510600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.580800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.285200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.024600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.754600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.118000E-02 |
| Normal-vs-N1 |
2.851000E-01 |
| Normal-vs-N2 |
6.817200E-03 |
| N0-vs-N1 |
5.417700E-02 |
| N0-vs-N2 |
1.277960E-02 |
| N1-vs-N2 |
3.439900E-03 |
|
|
